A pharmacist dilutes the Pfizer Covid-19 vaccine while preparing it to administer to staff and residents at the Goodwin House Bailey's Crossroads, a senior living community in Falls Church, Virginia, on December 30, 2020.
Covax programme is the main global scheme to vaccinate people in poorer countries around the world against coronavirus.
The announcement comes at a time when the WHO said that Africa stands to lose out on access to the Covid-19 vaccine.
Kenya could be part of the countries set to receive the Pfizer vaccine following the announcement of an agreement between American multinational pharmaceutical corporation Pfizer and BioNTech SE with the Covax Facility.
Kenya, which is one of the 92 countries that will receive the jabs, has already applied for 24 million vaccines and could either get the Oxford/AstraZeneca vaccine or the Pfizer BioNTech depending on the distribution by the Covax Facility.
